The rising burden of cancer globally has necessitated the adoption of developed cancer diagnostic solutions in the healthcare sector. It has a positive impact on the growth and expansion of the cancer diagnostics market at CAGR 11.8 %
Market Leading Players
C.R. Bard, Inc. (the U.S.), Philips Healthcare (the U.K.), Siemens Healthcare (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories, Inc. (the U.S.), QIAGEN N.V. (Netherlands), GE Healthcare (the U.K), Dickinson and Company (the U.S.), Becton, Illumina, Inc. (Denmark), Thermo Fisher Scientific, Inc. (the U.S.), Agilent Technologies, Inc. (the U.S.), Cancer Diagnostics, Inc. (the U.S.), Biotheranostics, Inc. (the U.S.), BioMark Diagnostics Inc. (Canada), Arquer Diagnostics Ltd (the U.K), Armune BioScience, Inc. (the U.S.), and others.
The cancer diagnostics market by technologyis exhibited to grow at a noteworthy 11.85% CAGR over the assessment period (2017-2023). In recent times, cancer is a highly emerging disease globally and the number one cause for deaths. Cancer is the growth of the tumor cells in any part of the body that is uncontrolled and can spread to the remaining parts. There are above 200 types of cancer of which lung, melanoma, ovarian, pancreatic, colorectal, kidney, blood, liver, breast and cervical cancer are the most common.
Cancer diagnosis during an early stage will help in curing the disease thereby limiting its severity. Independent and collaborative initiatives led by the companies and the governments are striving in raising cognizance regarding the advantages of early diagnosis of cancer. The substance that leads to cancer is known as carcinogen and the common causes of cancer include genetic or viral factors, environmental agents or molecules present in tobacco smoke.
Based on type - tumor cancer diagnostics, imaging procedure, endoscopy based, biopsy based and others. Of these, the imaging procedure will have the largest market share over the assessment period.
Based on application - pancreatic cancer, liver cancer, kidney cancer, blood cancer, skin cancer, prostate cancer, cervical cancer, colorectal cancer, breast cancer, lung cancer and others. Of these, breast cancer will have the maximum share in the market.
Based on end-user - it is segmented into research institutes, hospital, clinic, diagnostic center and others. Of these, hospital will have a robust growth over the assessment period.
Key Questions Answered in This Report:
- What will the market size and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
- Cancer specific medical device manufacturers
- Cancer specific medical device suppliers
- Government Research Laboratory
- Private Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Medical Research Laboratories
Access the complete report @ https://www.marketresearchfuture.com/reports/cancer-diagnostics-market-1962
Browse other healthcare-related reports
About Market Research Future:
MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.